Search results for "marque"

showing 10 items of 93 documents

Estimating the genetic diversity and structure ofQuercus trojanaWebb populations in Italy by SSRs: implications for management and conservation

2017

Studying the genetic diversity and structure of the current forest populations is essential for evaluating the ability to survive to future biotic and abiotic changes and planning conservation strategies. Quercus trojana is an eastern Mediterranean tree species with a fragmented distribution range, and its westernmost outposts are located in southern Italy. The demand for timber and cropland over the centuries has severely reduced it s occurrence in this part of the range. We assessed the genetic diversity and structure of the extant Italian populations of Q. trojana and derived conservation guidelines. A total of 322 samples were genotyped with six polymorphic nuclear microsatellite marker…

0106 biological sciences0301 basic medicineSettore AGR/05 - Assestamento Forestale E SelvicolturaQuercus trojana Genetic diversity Population structure SSRs markers ConservationQuercus trojanaRange (biology)PopulationConservationPopulation structure010603 evolutionary biology01 natural sciencesGenetic diversity03 medical and health sciencesQuercus trojanaeducationAbiotic componentQuercus trojana diversité génétique structure de populations marqueurs SSRs conservationGlobal and Planetary ChangeGenetic diversityeducation.field_of_studySSRs markersEcologybiologyEcologyForestrybiology.organism_classification030104 developmental biologyMicrosatelliteGene poolSpecies richnessCanadian Journal of Forest Research
researchProduct

Creiximent de la població, mortalitat, natalitat i migracions a les comarques de Tarragona (1700-1860)

2018

0210-9093 553 Estudis: Revista de historia moderna 500918 2018 44 6623956 Creiximent de la poblacióUNESCO::HISTORIAmortalitat:HISTORIA [UNESCO]natalitat i migracions a les comarques de Tarragona (1700-1860) Ferrer i AlòsRevista de historia moderna 500918 2018 44 6623956 Creiximent de la població [0210-9093 553 Estudis]Llorenç 197 223
researchProduct

Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for type 2 diabetes

2017

AbstractOur objectives were to determine if there are quantitative associations between amounts and intensities of physical activities (PA) on NMR biomarkers and changes in skeletal muscle gene expressions in subjects with high risk for type 2 diabetes (T2D) performing a 3-month PA intervention. We found that PA was associated with beneficial biomarker changes in a factor containing several VLDL and HDL subclasses and lipids in principal component analysis (P = <0.01). Division of PA into quartiles demonstrated significant changes in NMR biomarkers in the 2nd - 4th quartiles compared to the 1st quartile representing PA of less than 2850 daily steps (P = 0.0036). Mediation analysis of PA-…

0301 basic medicineBlood GlucoseMaleVery low-density lipoprotein[SDV]Life Sciences [q-bio]prévention des maladieslcsh:MedicineAdipose tissueMuscle ProteinsType 2 diabetes030204 cardiovascular system & hematologyOverweight0302 clinical medicinemaladie cardiovasculairelcsh:ScienceComputingMilieux_MISCELLANEOUSBODY-WEIGHT CHANGEMultidisciplinaryMiddle AgedMagnetic Resonance Imaging[SDV] Life Sciences [q-bio]ADIPOSE-TISSUEBiomarker (medicine)SKELETAL-MUSCLEFemalemedicine.symptombiomarqueurINSULIN-RESISTANCE ATHEROSCLEROSISAutre (Sciences du Vivant)Adultmedicine.medical_specialtydiabète de type 2expression géniqueCarbohydrate metabolismALL-CAUSEArticle03 medical and health sciencesMedical researchLIPID-METABOLISMInternal medicineDiabetes mellitusmedicineAPOLIPOPROTEIN-D POLYMORPHISMHumansObesityNUCLEAR-MAGNETIC-RESONANCEMuscle SkeletalExercisebusiness.industryMORTALITYlcsh:RLipid metabolismsurpoidsLIPOPROTEIN PARTICLE-SIZEmedicine.disease030104 developmental biologyEndocrinologyPHYSICAL-ACTIVITYDiabetes Mellitus Type 2Gene Expression Regulationlcsh:QbusinessBiomarkers
researchProduct

Intérêt du growth differentiation factor 15 (GDF15) comme biomarqueur pronostique après la survenue d'un Accident Vasculaire Cérébral ischémique (AVC)

2018

Introduction Le GDF15 est un biomarqueur de mauvais pronostic dans certaines pathologies cardiovasculaires comme le syndrome coronarien aigu. Son interet dans le domaine de AVC n’a ete que peu etudie a ce jour. Objectifs Notre travail consistait a l’evaluation des taux de GDF15 chez des patients hospitalises a la phase aigue d’un AVC ischemique traites par fibrinolyse et/ou thrombectomie. L’objectif principal etait d’evaluer l’association entre les taux de GDF15 et la recuperation fonctionnelle a 3 mois. Methodes Au total, 174 patients ont ete inclus entre le 16/01 et le 30/09/2017. Le consentement etait recueilli oralement. Des prelevements biologiques ont ete realises a l’admission du pat…

AVC03 medical and health sciencesRevascularisation0302 clinical medicineBiomarqueurNeurology[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]030212 general & internal medicineNeurology (clinical)ischémique[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology030217 neurology & neurosurgery
researchProduct

Les ambroisies annuelles (Ambrosia artemisiifolia et Ambrosia trifida) : réponse adaptative au désherbage chimique et connectivité des populations da…

2018

The primary aim of this work was to study the risk of resistance evolution to acetolactate synthase (ALS) inhibiting herbicides in mugwort (Ambrosia artemisiifolia L.) through four points: (i) selection pressure (study of the efficacy of a range of ALS-inhibiting herbicides), (ii) the adaptive response capacity of the weed (determination of the variation in sensitivity to ALS inhibitors between plants and implementation of a recurrent selection programme), (iii) a field study (search for resistance to ALS inhibitors in the field in France), (iv) the study of resistance mechanisms (target-linked - TLR - and non-target-linked - NLR - by a transcriptomics approach). The second objective was to…

Ambrosia artemisiifolia L.ambroisiesinhibiteurs de l’ALSmarqueurs microsatellites[SDE] Environmental SciencesALS inhibitors[SDE]Environmental Sciencesherbicide resistanceflux de gènesrésistance aux herbicidesmicrosatellite markersgene flowragweed
researchProduct

Otra visión de la historia del mueble. La evolución técnica, base de la formal

2008

La evolución del mobiliario no sólo está condicionada por la transformación en los estilos de vida, sino también por el desarrollo de técnicas de elaboración de la madera. Este artículo está dirigido a aquellos que investigan o se aproximan al mobiliario y las artes decorativas, con la intención de proporcionar una herramienta para la comprensión de la evolución constructiva y de las técnicas decorativas. (A)

Análisis técnicoUNESCO::HISTORIA::Historia por especialidades::Historia del arteMobiliarioTécnicas artísticasHistoria del arteTalleres artísticosEvolución históricaArtes decorativasDecoraciónTipologíaTapiceríaMueblesCarpinteríaEbanistería:HISTORIA::Historia por especialidades::Historia del arte [UNESCO]Marquetería
researchProduct

Señor. El Cabildo de la Santa Iglesia Metropolitana de la Ciudad de Lima, en Sede-vacante ... dice: Que por el Testimonio de Autos remitido à V. Ma…

1731

Com a tít. el començament del text Caplletres ornades Sign.: A4 Reclams

Armendáriz José Marqués de Castel-Fuerte Virrey del Perú Obres anteriors a 1800Armendáriz José Marqués de Castel-Fuerte Virrey del Perú Obres anteriors al 1800Immunitat eclesiàstica Obres anteriors a 1800Franciscans Lima (Perú) 1731 Obres anteriors al 1800Franciscans Lima (Perú) 1731 Obres anteriors a 1800Catedral de Lima 1731 Obres anteriors a 1800Catedral de Lima 1731 Obres anteriors al 1800Immunitat eclesiàstica Obres anteriors al 1800
researchProduct

Study of leurocyte telomere lenght and transcription in patients in the acute phase of myocardial infarction

2011

Atherosclerosis with cardiovascular complications remains today one of the leading causes of death in developed countries. In this context, development of new biomarkers of atherosclerosis has an important place. Objectives of these biomarkers are: • to identify populations most at risk of developing cardiovascular complications, • to stratify patient groups to optimize their clinical management and therapeutic, • to reveal new therapeutic targets in the treatment of the disease. In this context, we identified three biomarkers of interest, leukocyte telomere length (LTL) and level of expression of leukocyte genes c-Fos (involved in inflammatory processes and oxidative) and OGG1 (necessary r…

Bio-marqueursLongueur des télomères leucocytairesInflammationPathologies athéromateuses[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyC-FosTabacStress oxydatifNo english keywordsInfarctus du myocardeOGG1Statines
researchProduct

Nouvelles stratégies innovantes en immunothérapie

2018

Resume Les progres recents de l’immunotherapie en oncologie avec le developpement des anticorps anti-PD1/PD-L1 revolutionnent la prise en charge oncologique. L’immuno-oncologie se developpe ainsi dans la plupart des types histologiques de cancer. Malgre tout, l’utilisation des anticorps anti-PD1/PD-L1 en monotherapie est limitee par une reponse restreinte a une sous-population de malades representant environ 25-30 % des patients dans la plupart des indications. Le developpement de nouvelles strategies se base sur cette observation. Ainsi on note le developpement de differentes strategies ayant pour objectifs de mieux selectionner les malades ou de combiner les checkpoints inhibiteurs avec d…

BiomarqueursGynecology0303 health sciencesCancer Researchmedicine.medical_specialtybusiness.industryImmunothérapieImmune checkpoint inhibitorsChimio-immunothérapie[SDV.CAN]Life Sciences [q-bio]/CancerHematologyGeneral Medicine3. Good health03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisMedicineRadiology Nuclear Medicine and imagingImmunotherapybusinessBiomarkersCheckpoint inhibitors030304 developmental biologyBulletin du Cancer
researchProduct

Evaluation of proton MR spectroscopy at 3 Tesla without endorectal coil in patients with a localized prostate cancer treated with exclusive radiother…

2011

Prostate cancer is the most frequent tumour affecting the male population. When the prostate is not removed and is treated with radiation therapy, PSA slowly decreases over time to reach its nadir, even sometimes 18 to 24 months after the completion of radiation therapy without combined androgen suppression therapy. When combined with hormones, PSA falls abruptely with no possibility to perceive the impact of either hormones or radiation effects on PSA.The optimal value of PSA that should be reached after radiation therapy (nadir) and time to this nadir are still unclear.Even when a satisfactory value of the PSA nadir is reached, on-going variations of the PSA and its “bounce” effects, whic…

BiomarqueursRéponse thérapeutique[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyProstate cancerTherapeutic responseRadiotherapySpectroscopieCancer de la prostateIRM fonctionnelle[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyBiomarkersSpectroscopy[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyFunctional MRIRadiothérapie
researchProduct